Sort   by:  
 Page size 
GenomicsChIA-PET from SU-DHL-4 (ENCSR658RQQ)
RAD21 ChIA-PET in human SU-DHL-4 cells For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf
ORGANISM(S): Homo sapiens 
2019-03-03 | GSE127039 | GEO
GenomicsNext generation sequencing analysis of transcriptomes at different timepoints after CBL0137 treatment in SU-DHL-4, Raji and Jeko cell lines
Next generation sequencing analysis of transcriptomes at different timepoints after CBL0137 treatment in SU-DHL-4, Raji and Jeko cell lines
PRJNA860600 | ENA
GenomicsEffect of EZH2 inhibition and CART19 on gene expression of B-NHL cell lines (OCI-ly18 and SU-DHL-4)
Effect of EZH2 inhibition and CART19 on gene expression of B-NHL cell lines (OCI-ly18 and SU-DHL-4)
PRJNA1109534 | ENA
ProteomicsQuantitative Global and Phospho-proteomics analysis of rapamycin-treated human SU-DHL-4 cells by LC-MSMS
Global protein profiling and global phospho-protein profiling in human diffuse large B cell lymphoma cell line SU-DHL-4 treated with Rapamycin at two time points compared with DMSO control was performed by Poochon Scientific using the TMT-18plex labeling based quantitative proteomics method and liqu...
ORGANISM(S): Homo sapiens (Human) 
2025-09-03 | PXD067812 | Pride
Lc-msms Global protein profiling Rapamycin Su-dhl-4 Tmt multiplex Global phospho-protein profiling Dlbcl 
TranscriptomicsNext generation sequencing analysis of transcriptomes at different timepoints after CBL0137 treatment in SU-DHL-4, Raji and Jeko cell lines
To understand the mechanisms of CBL0137 in B-NHL therapy, gene expression changes of SU-DHL-4, Raji and Jeko cell lines after CBL0137 treatment were analyzed by RNA-seq
ORGANISM(S): Homo sapiens 
2023-02-07 | GSE208679 | GEO
Genomicsena-DATASET-DKFZ-IBIOS-17-08-2015-09:13:01:216-19 - samples
PAR-CLIP was performed on the Argonaute-2 protein (AGO2) in four lymphoma cell lines: Namalwa Raji SU-DHL-4 SU-DHL-6
EGAD00001001468 | EGA
TranscriptomicsGene expression analysis of Hodgkin and non-Hodgkin lymphoma cell lines
Genomewide gene expression analysis of lymphoid cell lines of Hodgkin, non-Hodgkin and acute leukemia origin Affymetrix U133 Plus 2.0 oligonucleotide arrays were hybridized to determine the gene expression profile of Hodgkin (L428, L1236, KM-H2, HDLM-2, L540, L540Cy), non-Hodgkin (Namalwa, SU-DHL-4)...
ORGANISM(S): Homo sapiens 
2010-11-17 | E-GEOD-20011 | biostudies-arrayexpress
ProteomicsLC-MSMS of 3 DLBCL cell lines (class I immunopeptidome and whole proteome)
Accumulating evidence indicates that alternative translation events occur in all cell types, suggesting that the proteome is more complex than previously anticipated. We elected to broaden the repertoire of human cryptic proteins by designing an approach combining ribosome profiling, which gives a p...
ORGANISM(S): Homo sapiens (Human) 
2020-11-16 | PXD020620 | Pride
Lc-msms Dlbcl Hbl-1 Dohh2 Immunopeptidome Proteome And su-dhl-4 Mhc class i 
TranscriptomicsGene expression profiling of EZH2 mutant and wild type DLBCL cell lines treated with EZH2 inhibitor
We studied transcriptional changes by Affymetrix human microarrays in DLBCL cell lines as a result of treatment with GSK126, a potent, highly-selective, SAM-competitive, small molecule inhibitor of EZH2 In eukaryotes, epigenetic post-translational modification of histones is critical for regulation ...
ORGANISM(S): Homo sapiens 
2012-10-12 | E-GEOD-40971 | biostudies-arrayexpress
TranscriptomicsDeciphering the Mechanisms of CC-122 Resistance in DLBCL via a Genome-Wide Screen
CC-122 is a next-generation cereblon E3 ligase modulating agent that has demonstrated promising clinical efficacy in relapsed or refractory diffuse large B‐cell lymphoma (R/R DLBCL) patients. Mechanistically, CC-122 induces the degradation of IKZF1/3, leading to T cell activation and robust cell-aut...
ORGANISM(S): Homo sapiens 
2020-10-01 | GSE158303 | GEO
Sort   by:  
 Page size